An update on antiepileptic drugs and suicide: are there definitive answers yet?

Area of Science:

• Neurology
• Pharmacology
• Psychiatry

Background:

• The Food and Drug Administration (FDA) warned in 2008 about increased suicide risk with antiepileptic drugs (AEDs).
• This warning caused significant confusion regarding AED use, particularly for epilepsy patients.
• Recent studies analyzing suicidality and AEDs revealed biases affecting findings.

Purpose of the Study:

• To clarify methodological issues in research assessing the link between AEDs and suicidality.
• To address contradictions in existing studies concerning AEDs and suicide risk.
• To critically evaluate the evidence supporting the FDA's 2008 warning.

Main Methods:

• Review of recent publications on AEDs and suicidality.
• Analysis of biases in database studies, including indication for prescription and monitoring intensity.
• Examination of statistical methods, such as controlling for multiple comparisons.

Main Results:

• Existing studies failed to adequately control for confounding factors like the reason for AED prescription.
• Inconsistent monitoring of patients for suicidality across studies complicates findings.
• Numerous statistical analyses and comparisons within studies led to contradictory results.
• No study provided convincing evidence to fully support the FDA's conclusions on AEDs and suicide risk.

Conclusions:

• Methodological limitations in current research obscure the true relationship between AEDs and suicidality.
• Further research with robust controls is needed to accurately assess suicide risk associated with AEDs.
• The FDA's 2008 warning requires re-evaluation based on flawed supporting evidence.